Anti-CD45 pretargeted radioimmunotherapy in a nonhuman primate model

被引：0
|
作者：
Green, Damian J. [1 ,3 ]
Pagel, John M. [1 ,3 ]
Nemecek, Eneida R. [2 ]
Pantelias, Anastasia [1 ]
Lin, Yukang [1 ]
Kenoyer, Aimee L. [1 ]
Fisher, Darrell R. [4 ]
Wilbur, D. S. [3 ]
Hamlin, Donald K. [3 ]
Gopal, Ajay K. [1 ,3 ]
Press, Oliver W. [1 ,3 ]
机构：
[1] FHCRC, Seattle, WA USA
[2] Oregon Hlth & Sci Univ, Portland, OR USA
[3] Univ Washington, Seattle, WA USA
[4] Pacific NW Natl Lab, Richland, WA 99352 USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2336
引用
收藏
页码：691A / 691A
页数：1
相关论文
共 50 条
  • [1] Pretargeted radioimmunotherapy (PRIT) with an anti-CD45 fusion protein to improve radionuclide delvery in nonhuman primates
    Green, D. J.
    Pagel, J. M.
    Nemecek, E. R.
    Pantelias, A.
    Lin, Y.
    Kenoyer, A. L.
    Fisher, D. R.
    Wilbur, D. S.
    Hamlin, D. K.
    Gopal, A. K.
    Press, O. W.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 522 - 522
  • [2] Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy
    Pagel, John M.
    Hedin, Nathan
    Drouet, Lacey
    Wood, Brent L.
    Pantelias, Anastasia
    Lin, Yukang
    Hamlin, Donald K.
    Wilbur, D. Scott
    Gopal, Ajay K.
    Green, Damian
    Appelbaum, Frederick R.
    Pressl, Oliver W.
    [J]. BLOOD, 2008, 111 (04) : 2261 - 2268
  • [3] Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model
    Nemecek, ER
    Hamlin, DK
    Fisher, DR
    Krohn, KA
    Pagel, JM
    Appelbaum, FR
    Press, OW
    Matthews, DC
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (02) : 787 - 794
  • [4] Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
    Pagel, JM
    Hedin, N
    Subbiah, K
    Meyer, D
    Mallet, R
    Axworthy, D
    Theodore, LJ
    Wilbur, DS
    Matthews, DC
    Press, OW
    [J]. BLOOD, 2003, 101 (06) : 2340 - 2348
  • [5] Optimal preloading in radioimmunotherapy with anti-CD45 antibody
    Kletting, Peter
    Kull, Thomas
    Bunjes, Donald
    Luster, M.
    Reske, Sven N.
    Glatting, Gerhard
    [J]. MEDICAL PHYSICS, 2011, 38 (05) : 2572 - 2578
  • [6] Improving Radioimmunotherapy with Anti-CD45 Antibody by Optimising the Preload
    Kletting, P.
    Glatting, G.
    Reske, S. N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S170 - S170
  • [7] Improving Anti-CD45 Antibody Radioimmunotherapy Using a Physiologically Based Pharmacokinetic Model
    Kletting, Peter
    Bunjes, Donald
    Reske, Sven N.
    Glatting, Gerhard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (02) : 296 - 302
  • [8] Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia
    Pagel, John M.
    Matthews, Dana C.
    Kenoyer, Aimee
    Hamlin, Donald K.
    Wilbur, Daniel S.
    Fisher, Darrell R.
    Gopal, Ajay K.
    Lin, Yukang
    Saganic, Laura
    Appelbaum, Frederick R.
    Press, Oliver W.
    [J]. CANCER RESEARCH, 2009, 69 (01) : 185 - 192
  • [9] Biodistribution of Yttrium-90 [90Y] labeled anti-CD45 antibody in a nonhuman primate model.
    Nemecek, ER
    Hamlin, DK
    Fisher, DR
    Krohn, KA
    Pagel, JM
    Appelbaum, FR
    Press, OW
    Matthews, DC
    [J]. BLOOD, 2003, 102 (11) : 457A - 457A
  • [10] Radioimmunotherapy (RIT) with anti-CD45 antibody: Optimal timing of the preload
    Kletting, Peter
    Reske, Sven
    Glatting, Gerhard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345